SINGLETON J MATTHEW

CIK 00012435142 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001243514

Recent Transactions

50 trades

Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2026-01-02+20,400→ 20,400 total
Award
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2026-01-02+3,150→ 12,650 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2025-01-02+18,800→ 18,800 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-10-25−16,000→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-10-25$79.50/sh−16,000→ 9,500 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-10-25$4.48/sh+16,000→ 25,500 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-09-20−10,300→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-09-20$69.50/sh−10,300→ 9,500 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-09-20$1.19/sh+10,300→ 19,800 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-21$1.19/sh+5,700→ 15,200 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-08-21−5,700→ 10,300 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-21$69.72/sh−5,700→ 9,500 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-08-19−16,000→ 0 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$60.01/sh−2,500→ 23,000 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$61.86/sh−4,509→ 15,444 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$3.33/sh+16,000→ 25,500 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$61.13/sh−3,047→ 19,953 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$63.15/sh−2,055→ 13,389 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$64.10/sh−2,388→ 11,001 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-19$64.88/sh−1,501→ 9,500 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-14$57.52/sh−20,626→ 9,660 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-14$8.00/sh+20,786→ 30,286 total
Sale
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2024-08-14$58.37/sh−160→ 9,500 total
Exercise/Conversion
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-08-14−20,786→ 0 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2024-01-02+32,000→ 32,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2023-01-03+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2022-01-03+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2021-01-04+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2020-01-02+22,000→ 22,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2019-01-02+22,000→ 22,000 total
Purchase
Viking Therapeutics, Inc.$VKTX
Common Stock, par value $0.00001 per share
2018-05-31$9.82/sh+9,500→ 9,500 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2018-01-02+16,000→ 16,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2017-01-03+16,000→ 16,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2016-01-04+16,000→ 16,000 total
Award
Viking Therapeutics, Inc.$VKTX
Stock Option (Right to Buy)
2015-04-28+20,786→ 20,786 total
Award
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-12+1,104→ 1,104 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2013-06-12+8,370→ 8,370 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-06−1,347→ 0 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2013-06-06+1,347→ 4,972 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2013-05-22$9.56/sh+10,000→ 13,625 total
Sale
CUBIST PHARMACEUTICALS INC
Common Stock
2013-05-22$55.48/sh−27,500→ 3,625 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2013-05-22$22.71/sh+17,500→ 31,125 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2013-05-22−17,500→ 0 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2013-05-22−10,000→ 0 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2012-08-24−2,500→ 0 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2012-08-24$10.09/sh+2,500→ 6,125 total
Sale
CUBIST PHARMACEUTICALS INC
Common Stock
2012-08-24$45.52/sh−2,500→ 3,625 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2012-06-06+9,367→ 9,367 total
Award
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2012-06-06+1,347→ 1,347 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2012-03-09+10,000→ 13,625 total

Companies

Recent Filings

Address

65 HAYDEN AVENUE

LEXINGTON, MA, 02421

View on SEC.gov